Alon Ruth bought SLXN
February 9, 2025 · Form 4 insider transaction
Alon Ruth bought 935 shares of Silexion Therapeutics Corp at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 325 days after the transaction.
Direction
Acquired (buy-side)
Shares
935
Price
$0.00
Total value
N/A
InsiderAlon Ruth
Role—
SecurityStock Option (right to buy ordinary shares)
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2025
Filing dateDecember 31, 2025
Shares owned after935
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025.